Keywords: Dr Reddy's, Neulastim, Peg-grafeel, Roche

Dr Reddy’s launches Neulastim copy in India; doubles 4th-qtr profit

Article | 16 May 2011

Print This

Hyderabad, India-based generic drugmaker Dr Reddy’s Laboratories (NYSE: RDY) has launched its Peg-grafeel, the firm’s brand ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in